title: An amino acid mixture enhances insulin-stimulated glucose uptake in isolated rat epitrochlearis muscle.
abstract: Protein and certain amino acids (AA) have been found to lower blood glucose. Although these glucose-lowering AA are important modulators of skeletal muscle metabolism, their impact on muscle glucose uptake remains unclear. We therefore examined how an AA mixture consisting of 2 mM isoleucine, 0.012 mM cysteine, 0.006 mM methionine, 0.0016 mM valine, and 0.014 mM leucine impacts skeletal muscle glucose uptake in the absence or presence of a submaximal (sINS) or maximal insulin (mINS) concentration. The AA mixture, sINS, and mINS significantly increased 2-[(3)H]deoxyglucose (2-DG) uptake by 63, 79, and 298% above basal, respectively. When the AA mixture was combined with sINS and mINS, 2-DG uptake was further increased significantly by 26% (P = 0.028) and 14% (P = 0.032), respectively. Western blotting analysis revealed that the AA mixture increased basal and sINS Akt substrate of 160 kDa (AS160) phosphorylation, while AA mixture did not change phosphorylation of Akt or mammalian target of rapamycin (mTOR) under these conditions. Interestingly, addition of the AA mixture to mINS increased phosphorylation of mTOR, Akt as well as AS160, compared with mINS alone. These data suggest that certain AA increase glucose uptake in the absence of insulin and augment insulin-stimulated glucose uptake in an additive manner. Furthermore, these effects appear to be mediated via a pathway that is independent from the canonical insulin cascade and therefore may prove effective as an alternative therapeutic treatment for insulin resistance.
authors.affiliation: Department of Kinesiology and Health Education, University of Texas at Austin, Austin, Texas 78712, USA.
authors.forename: Maximilian
authors.initials: M
authors.lastname: Kleinert
authors.forename: Yi-Hung
authors.initials: YH
authors.lastname: Liao
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Nelson
authors.forename: Jeffrey R
authors.initials: JR
authors.lastname: Bernard
authors.forename: Wanyi
authors.initials: W
authors.lastname: Wang
authors.forename: John L
authors.initials: JL
authors.lastname: Ivy
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism*; D000818:Animals; D001692:Biological Transport; D015153:Blotting, Western; D003545:Cysteine / Q000378:metabolism; D003847:Deoxyglucose / Q000378:metabolism*; D004734:Energy Metabolism; D020690:GTPase-Activating Proteins / Q000378:metabolism; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D007532:Isoleucine / Q000378:metabolism; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D008297:Male; D008715:Methionine / Q000378:metabolism; D018482:Muscle, Skeletal / Q000378:metabolism*; D010725:Phosphocreatine / Q000378:metabolism; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism; D014404:Tubulin / Q000378:metabolism; D014633:Valine / Q000378:metabolism
chemical_list: D000596:Amino Acids; D020690:GTPase-Activating Proteins; D007328:Insulin; C533101:TBC1D4 protein, rat; D014404:Tubulin; D010725:Phosphocreatine; D007532:Isoleucine; D000255:Adenosine Triphosphate; D003847:Deoxyglucose; D008715:Methionine; C546845:mTOR protein, rat; D051057:Proto-Oncogene Proteins c-akt; D058570:TOR Serine-Threonine Kinases; D007930:Leucine; D014633:Valine; D003545:Cysteine